BCL9 and ductal breast carcinoma in situ: To determine whether BCL9 regulated the expression of integrin β3 through canonical Wnt signaling, we stimulated DCIS.COM BCL9 NS and KD cells with Wnt3 ligand and measured integrin β3 expression by QPCR.